National Planning Corporation’s Sarepta Therapeutics SRPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q4
Sell
-5,023
Closed -$228K 521
2017
Q3
$228K Sell
5,023
-800
-14% -$36.3K 0.02% 593
2017
Q2
$203K Sell
5,823
-2,850
-33% -$99.4K 0.02% 681
2017
Q1
$250K Sell
8,673
-5,600
-39% -$161K 0.02% 565
2016
Q4
$413K Sell
14,273
-1,500
-10% -$43.4K 0.03% 417
2016
Q3
$613K Sell
15,773
-280
-2% -$10.9K 0.05% 321
2016
Q2
$410K Buy
16,053
+2,375
+17% +$60.7K 0.03% 420
2016
Q1
$242K Buy
13,678
+275
+2% +$4.87K 0.02% 529
2015
Q4
$164K Buy
13,403
+3,130
+30% +$38.3K 0.01% 659
2015
Q3
$258K Buy
10,273
+3,000
+41% +$75.3K 0.02% 496
2015
Q2
$244K Buy
+7,273
New +$244K 0.02% 522
2015
Q1
Sell
-7,623
Closed -$114K 1864
2014
Q4
$114K Buy
+7,623
New +$114K 0.01% 870